Join us for a joint scientific symposium of EPFL and Institut Pasteur—a one-day exploration of cutting-edge research and innovation at the forefront of biomedical science.
We bring together leading minds from the two institutions across the fields of AI, structural biology, drug discovery, cancer research, vaccines and immunology, and material sciences, all with a shared mission: advancing our understanding, strategies and approaches towards new therapeutics and vaccines.
📅 November 13, 2023
🕘 9:00 – 17:30
📍 EPFL SV 1717 – retransmission to Institut Pasteur (room tbc)
- Andrea Ablasser – Innate Immunity
- Aleksandar Antanasijevic – Virology and Structural Immunology
- Maartje Bastings – Programmable Biomaterials
- Bruno Correia – Protein Design and Immunoengineering
- Christian Heinis – Therapeutic Proteins and Peptides
- Wouter Karthaus – Endocrine Therapy Resistance and Molecular Genetics
- Christophe Merten – Biomedical Microfluidics
- Phillippe Schwaller – Therapeutic Proteins and Peptides
- Francesco Stellacci – Supramolecular Nano-Materials and Interfaces
- Nico Thomä – Paternot Chair of Cancer Research
- Paola Arimondo – Epigenetic Chemical Biology
- Chetan Chitnis – Malaria Parasite Biology and Vaccines
- James Di Santo – Innate Immunity
- Pablo Guardado-Calvo – Structural Biology of Infectious Diseases
- Laurence Mulard – Chemistry of Biomolecules
- Asier Sáez-Cirión – Viral Resevoirs and Immune Control
- Olivier Sperandio – Structural Bioinformatics
Program
- Christophe Mertens, EPFL – Droplet microfluidics in personalized cancer therapy and antibody discovery
- James Di Santo, Institut Pasteur – Innate lymphoid cell therapies and CVI presentation
- Wouter Karthaus, EPFL – Targeting lineage plasticity in prostate cancer using next generation organoid modeling
- Maartje Bastings, EPFL – Engineering super-selective functional materials: a balancing act of rigidity and geometry at the nanoscale
- Olivier Sperandio, Institut Pasteur – Data-driven and artificial intelligence approaches to the design of therapeutic compounds against macromolecular interaction
- Philippe Schwaller, EPFL – Learning the Language of Chemistry
- Pablo Guardado-Calvo, Institut Pasteur – Structural biology approaches to design immunogens and improve therapeutic antibodies
- Nico Thomä, EPFL – Haven’t got a glue: how small molecules rewire protein-protein interactions
- Andrea Ablasser, EPFL – Innate immune sensing of DNA
- Chetan Chitnis, Institut Pasteur – Developing a vaccine for Plasmodium vivax malaria – the value of a challenge model
- Aleksandar Antanasievic, EPFL – Antibody responses visualized by cryoEM – Applications to vaccine and toxin research
- Paola Arimondo, Institut Pasteur – Allying Chemistry and Biology to tackle the Epigenetics of Infection
- Asier Saez-Cirion, Institut Pasteur – T cell metabolism in HIV control
- Francesco Stellacci, EPFL – Virucidal Broadspectrum Antivirals
- Laurence Mulard, Institut Pasteur – A journey to a first-in-human synthetic glycan-based vaccine
- Christian Heinis, EPFL – Development of cyclic peptide-based ligands to intracellular protein targets
- Bruno Correia, EPFL – Computational design of protein structure and function using deep learning
Hosts: Andy Oates (EPFL) and Stewart Cole (Institut Pasteur)
Academic committee: Matteo Dal Peraro (EPFL), Michael Nilges (Institut Pasteur)
Please contact [email protected] for all inquiries.